Abstract
Aim:
To investigate the effect of the peroxisome proliferator-activator receptor (PPAR)-γ agonist, pioglitazone, on insulin resistance in low-dose streptozotocin and high sucrose-fat diet induced obese rats.
Methods:
Normal female Wistar rats were injected intraperitoneally with low-dose streptozotocin (STZ, 30 mg/kg) and fed with a high sucrose-fat diet for 8 weeks. Pioglitazone (20 mg/kg) was administered orally to the obese and insulin-resistant rats for 28 d. Intraperitoneal glucose tolerance tests, insulin tolerance tests and gluconeogenesis tests were carried out over the last 14 d. At the end of d 28 of the treatment, serums were collected for biochemical analysis. Glucose transporter 4 (GLUT4) and insulin receptor substrate-1 (IRS-1) protein expression in the liver and skeletal muscle were detected using Western blotting.
Results:
Significant insulin resistance and obesity were observed in low-dose STZ and high sucrose-fat diet induced obese rats. Pioglitazone (20 mg/kg) treatment significantly decreased serum insulin, triglyceride and free fatty acid levels, and elevated high density lipoprotein-cholesterol (HDL-C) levels. Pioglitazone also lowered the lipid contents in the liver and muscles of rats undergoing treatment. Gluconeogenesis was inhibited and insulin sensitivity was improved markedly. The IRS-1 protein contents in the liver and skeletal muscles and the GLUT4 contents in skeletal muscle were elevated significantly.
Conclusion:
The data suggest that treatment with pioglitazone improves insulin sensitivity in low-dose STZ and high sucrose-fat diet induced obese rats. The insulin sensitizing effect may be associated with ameliorating lipid metabolism, reducing hyperinsulinemia, inhibiting gluconeogenesis, and increasing IRS-1 and GLUT4 protein expression in insulin-sensitive tissues.
Similar content being viewed by others
Article PDF
References
Defronzo RA, Bonadonna RC, Ferrannini E . Pathogenesis of NIDDM. A balanced overview. Diabetes Care 1992; 15: 318–68.
Hallfrisch J, Lazar F, Jorgensen C, Reiser S . Insulin and glucose responses in rats fed sucrose or starch. Am J Clin Nutr 1979; 32: 787–93.
Xie MZ, Liu HF, Zhang LY, Shen ZF, Chen QM . An experimental rat model of obesity and diabetes. Acta Pharm Sin 1985; 20: 801–6.
Suter SL, Nolan JJ, Wallace P, Gumbiner B, Olefsky JM . Metabolic effects of new oral hypoglycemic agent CS-045 in NIDDM subjects. Diabetes Care 1992; 15: 193–203.
Nolan JJ, Ludvik B, Beerdsen P, Joyce M, Olefsky J . Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. N Engl J Med 1994; 331: 1188–93.
Ikeda H, Taketomi S, Sugiyama Y, Shimura Y, Sohda T, Meguro K, et al. Effects of pioglitazone on glucose and lipid metabolism in normal and insulin resistant animals. Arzneimittelforschung 1990; 40: 156–62.
Oakes ND, Camilleri S, Furler SM, Chisholm DJ, Kraegen EW . The insulin sensitizer, BRL 49653, reduces systemic fatty acid supply and utilization and tissue lipid availability in the rat. Metabolism 1997; 46: 935–42.
Klip A, Ramlal T, Young DA, Holloszy JO . Insulin-induced translocation of glucose transporters in rat hindlimb muscles. FEBS Lett 1987; 224: 224–30.
Hotamisligil GS, Budavari A, Murray D, Spiegelman BM . Reduced tyrosine kinase activity of the insulin receptor in obesitydiabetes. Central role of tumor necrosis factor-alpha. J Clin Invest 1994; 94: 1543–9.
Saad MJ, Folli F, Kahn JA, Kahn CR . Modulation of insulin receptor, insulin receptor substrate-1, and phosphatidylinositol 3-kinase in liver and muscle of dexamethasone-treated rats. J Clin Invest 1993; 92: 2065–72.
Perriello G, Misericordia P, Volpi E, Pampanelli S, Santeusanio F, Brunetti P, et al. Contribution of obesity to insulin resistance in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1995; 80: 2464–9.
Kraegen EW, James DE, Storlien LH, Burleigh KM, Chisholm DJ . In vivo insulin resistance in individual peripheral tissues of the high fat fed rat: assessment by euglycaemic clamp plus deoxyglucose administration. Diabetologia 1986; 29: 192–8.
Pascoe WS, Storlien LH . Inducement by fat feeding of basal hyperglycemia in rats with abnormal β-cell function: model for study of etiology and pathogenesis of NIDDM. Diabetes 1990; 39: 226–33.
Ding SY, Shen ZF, Chen YT, Xie MZ . Evaluation on two insulin resistance rat models by euglycemic clamp technique. Chin J Diabetes 2001; 9: 286–90.
Terrettaz J, Assimacopoulos-Jeannet F, Jeanrenaud B . Severe hepatic and peripheral insulin resistance as evidenced by euglycemic clamps in genetically obese fa/fa rats. Endocrinology 1986; 118: 674–8.
Kim JK, Fillmore JJ, Chen Y, Yu C, Moore IK, Pypaert M, et al. Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance. Proc Natl Acad Sci USA 2001; 98: 7522–7.
Ciaraldi TP, Gilmore A, Olefsky JM, Goldberg M, Heidenreich KA . In vitro studies on the action of CS-045, a new antidiabetic agent. Metabolism 1990; 39: 1056–62.
Sevilla L, Guma A, Enrique-Tarancon G, Mora S, Munoz P, Palacin M, et al. Chronic high-fat feeding and middle-aging reduce in an additive fashion Glut4 expression in skeletal muscle and adipose tissue. Biochem Biophys Res Commun 1997; 235: 89–93.
Garvey WT, Huecksteadt TP, Birnbaum MJ . Pretranslational suppression of an insulin-responsive glucose transporter in rats with diabetes mellitus. Science 1989; 245: 60–3.
Kanai F, Ito K, Todaka M, Hayashi H, Kamohara S, Ishii K, et al. Insulin-stimulated GLUT4 translocation is relevant to the phosphorylation of IRS-1 and the activity of PI-3 kinase. Biochem Biophys Res Commun 1993; 195: 762–8.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ding, Sy., Shen, Zf., Chen, Yt. et al. Pioglitazone can ameliorate insulin resistance in low-dose streptozotocin and high sucrose-fat diet induced obese rats. Acta Pharmacol Sin 26, 575–580 (2005). https://doi.org/10.1111/j.1745-7254.2005.00090.x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1745-7254.2005.00090.x
Keywords
This article is cited by
-
Pioglitazone Antagonized the Effects of Advanced Glycation End Products on Achilles Tendon Healing and Improved the Recovery of Tendon Biomechanical Properties
Cellular and Molecular Bioengineering (2024)
-
Diabetes Worsens Functional Outcomes in Young Female Rats: Comparison of Stroke Models, Tissue Plasminogen Activator Effects, and Sexes
Translational Stroke Research (2017)
-
Gender-specific differences in PPARγ regulation of follicular helper T cell responses with estrogen
Scientific Reports (2016)
-
Effect of metformin and pioglitazone on β-catenin and biochemical markers in sitagliptin-induced pancreatitis in diabetic rats
International Journal of Diabetes in Developing Countries (2015)
-
Early diabetes treatment does not prevent sympathetic dysinnervation in the streptozotocin diabetic rat heart
Journal of Nuclear Cardiology (2014)